References
1. Hume D. Philosophical Essays Concerning Human UnderstandingLondon:Millar; 1748.
2. Steel D. Causal Inference and Medical Experiments. In: Gifford. F, ed. Handbook of the Philosophy of Science. Volume 16: Philosophy of Medicine. (Gabbay DM, Thagard P, Woods J, eds). Vol 16. London: Elsevier BV.; 2010.
3. Djulbegovic B, Guyatt GH, Ashcroft RE. Epistemologic inquiries in evidence-based medicine. Cancer Control. 2009;16(2):158-168.
4. Djulbegovic B, Guyatt GH. Progress in evidence-based medicine: a quarter century on. Lancet. 2017;390(10092):415-423.
5. Hill AB. The clinical trial. N Engl J Med. 1952(247):113-119.
6. Matthews JR. Quantification and quest for medical certainty.Princeton, NY: Princeton University Press; 1995.
7. Micheel CM, Nass SJ, Omenn GS, eds., eds. Evolution of Translational Omics: Lessons Learned and the Path Forward.Washington,DC: The National Academies Press; 2012.
8. Collins R, Bowman L, Landray M, Peto R. The Magic of Randomization versus the Myth of Real-World Evidence. New England Journal of Medicine. 2020;382(7):674-678.
9. Glasziou P, Chalmers I, Rawlins M, McCulloch P. When are randomised trials unnecessary? Picking signal from noise. BMJ.2007;334(7589):349-351.
10. Gigerenzer G, Brighton H. Homo heuristicus: why biased minds make better inferences. Top Cogn Sci. 2009;1(1):107-143.
11. Gigerenzer G, Hertwig R, Pachur T, eds. Heuristics. The foundation of adaptive behavior. New York: Oxford University Press; 2011.
12. Hozo I, Djulbegovic B, Luan S, Tsalatsanis A, Gigerenzer G. Towards theory integration: Threshold model as a link between signal detection theory, fast-and-frugal trees and evidence accumulation theory. J Eval Clin Pract. 2017;23(1):49-65.
13. Luan S, Schooler LJ, Gigerenzer G. A signal-detection analysis of fast-and-frugal trees. Psychol Rev. 2011;118(2):316-338.
14. Sherman RE LJ, Shapley S, Robb M, Woodcock J: Expediting. Expediting Drug Development — The FDA’s New “Breakthrough Therapy” Designation. . New England Journal of Medicine. 2013(369(20):1877-1880).
15. Djulbegovic B, Glasziou P, Klocksieben FA, et al. Larger effect sizes in nonrandomized studies are associated with higher rates of EMA licensing approval. Journal of Clinical Epidemiology.2018;98:24-32.
16. Razavi M, Glasziou P, Klocksieben FA, Ioannidis JPA, Chalmers I, Djulbegovic B. US Food and Drug Administration Approvals of Drugs and Devices Based on Nonrandomized Clinical Trials: A Systematic Review and Meta-analysis. JAMA Network Open. 2019;2(9):e1911111-e1911111.
17. Guyatt GH, Oxman AD, Montori V, et al. GRADE guidelines: 5. Rating the quality of evidence-publication bias. J Clin Epidemiol. 2011.
18. Gigerenzer G, Todd P, ABC-Research-Group. Simple heuristics that make us smart. 1999.
19. Hastie R, Dawes RM. Rational choice in an uncertain world.2nd edition. Los Angeles: Sage Publications, Inc.; 2010.
20. Lanzara RG. Weber’s law modeled by the mathematical description of a beam balance. Math Biosci. 1994;122(1):89-94.
21. Batschelet E. Introduction to Mathematics for Life Scientists. New York: Springer-Verlag; 1979.
22. Dehaene S. The neural basis of the Weber-Fechner law: a logarithmic mental number line. Trends in Cognitive Sciences.2003;7(4):145-147.
23. Pleskac TJ. A signal detection analysis of the recognition heuristic. Psychon Bull Rev. 2007;14(3):379-391.
24. Wasserstein RL, Lazar NA. The ASA’s Statement on p-Values: Context, Process, and Purpose. The American Statistician.2016;70(2):129-133.
25. Amrhein V, Greenland S, McShane B. Scientists rise up against statistical significance. Nature. 2019;567(7748):305-307.
26. Kashoki M, Hanaizi Z, Yordanova S, et al. A Comparison of EMA and FDA Decisions for New Drug Marketing Applications 2014-2016: Concordance, Discordance, and Why. Clin Pharmacol Ther.2020;107(1):195-202.
27. Stevens SS. Neural events and the psychophysical law.Science. 1970;170(962):1043-1050.
28. Rescher N. Epistemetrics.
. New York: Cambridge University Press; 2006.
29. Thaller RH. The winner’s Curse. Paradoxes and Anomalies of Economic Life. Princeton, New Jersey: Princeton University Press; 1992.
30. Kacelnik A, Brito e Abreu F. Risky Choice and Weber’s Law.Journal of Theoretical Biology. 1998;194(2):289-298.
31. Brandstatter E, Gigerenzer G. The Priority Heuristic: Making Choices Without Trade-Offs. Psychological Review 2006;113:409-432.
32. Converse BA, Dennis PJ. The role of “Prominent Numbers” in open numerical judgment: Strained decision makers choose from a limited set of accessible numbers. Organizational Behavior and Human Decision Processes. 2018;147:94-107.
33. Kent DM, Hayward RA. Limitations of Applying Summary Results of Clinical Trials to Individual Patients: The Need for Risk Stratification. JAMA. 2007;298(10):1209-1212.
34. Simon HA. Invariants of human behavior. . Annual Review of Psychology. 1990;41:1-19.
35. Pachur T, Todd P, Gigerenzer G, Schooler L, Goldstein D. The Recognition Heuristic: A Review of Theory and Tests. Frontiers in Psychology. 2011;2(147).
36. Pleskac TJ. A signal detection analysis of the recognition heuristic. . Psychon Bull Rev 2007;14(3):379-379.
37. Stanislaw H, Todorov N. Calculation of signal detection theory measures. Behav Res Methods Instrum Comput. 1999;31(1):137-149.
38. Glasziou P, Chalmers I, Rawlins M, McCulloch P. When are randomised trials unnecessary? Picking signal from noise. BMJ.2007;334(7589):349-351.
39. Gigerenzer G, Gaissmaier W, Kurz-Milcke E, Schwartz L, Woloshin S. Helping doctors and patients make sense of health statistics.Psychol Sci Public Interest. 2007;8(2):53 - 96.
40. Djulbegovic B, Elqayam S. Many faces of rationality: Implications of the great rationality debate for clinical decision-making. J Eval Clin Pract. 2017;23(5):915-922.
41. Elqayam S. Grounded rationality:descriptivism in epistemic context.Synthese. 2012;189:39-49.
42. Elqayam S, Evans JSBT. Subtracting ’ought’ from ’is’: Descriptivism versus normativism in the study of human thinking. . Behavioral and Brain Sciences. 2011;34:233-248.
43. Simon HA. Models of man: social and rational. Mathematical essays on rational human behavior New York: Wiley; 1957.
44. Katsikopoulos KV, Gigerenzer G. One-reason decision-making: Modeling violations of expected utility theory. Journal of Risk and Uncertainty. 2008;37(1):35.
45. Gigerenzer G. A Theory Integration Program. Decision.2017;81(3):133–145.
46. Elqayam S, Thompson VA, Wilkinson MR, Evans JS, Over DE. Deontic introduction: A theory of inference from is to ought. J Exp Psychol Learn Mem Cogn. 2015;41(5):1516-1532.
47. Djulbegovic B, Hozo I. When Should Potentially False Research Findings Be Considered Acceptable? PLoS Medicine. 2007;4(2):e26.
48. Wileyto EP, Audrain-McGovern J, Epstein LH, Lerman C. Using logistic regression to estimate delay-discounting functions. Behavior Research Methods, Instruments, & Computers. 2004;36(1):41-51.